Clinical evidence of efficient tumor targetting based on single–chain Fv antibody selected from a combinatorial library (original) (raw)

• Chester, K.A. & Hawkins, R.E. Clinical issues in antibody design. Trends Biotechnol. 13, 294–300 (1995).
  Article CAS Google Scholar
• Yokota, T., Milenic, D.E., Whitlow, M. & Schlom, J. Rapid tumour penetration of a single-chain Fv and comparison with other immunoglobulin forms. Cancer Res. 52, 3402–3408 (1992).
  CAS PubMed Google Scholar
• Huston, J.S. et al. Protein engineering of antibody binding sites: Recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in. Escherichia coll Proc Natl. Acad. Sci. USA 85, 5879–5883 (1988).
  Article CAS Google Scholar
• Colcher, D. et al. In vivo tumor targeting of a recombinant single-chain antigen-binding protein. J. Natl Cancer Inst 82, 1191–1197 (1990).
  Article CAS Google Scholar
• Milenic, D.E. et al Construction, binding properties, metabolism, and tumor targeting of a single chain Fv derived from the pancarcinoma monoclonal antibody CC49. Cancer Res. 51, 6363–6371 (1991).
  CAS PubMed Google Scholar
• Savage, P. et al Construction, characterisation and kinetics of a single chain antibody recognising the tumour associated antigen placental alkaline phos-phatase. Br. J. Cancer 68, 738–742 (1993).
  Article CAS Google Scholar
• Huse, W.E. et al Generation of a large combinatorial library of the immunolog-ical repertoire in phage lambda. Science 246, 1275–1281 (1989).
  Article CAS Google Scholar
• McCafferty, J., Griffiths, A.D., Winter, G. & DJ.Phage antibodies: Filamentous phage displaying antibody variable domains. Nature 348, 552–554 (1990).
  Article CAS Google Scholar
• Clackson, T., Hoogenboom, H.R., Griffiths, A.D. & Winter, G. Making antibody fragments using phage display libraries. Nature 352, 624–628 (1991).
  Article CAS Google Scholar
• Hawkins, R.E., Russell, S.J. & Winter, G. Selection of phage antibodies by binding affinity: Mimicking affinity maturation. J. Mol Biol. 226, 889–896 (1992).
  Article CAS Google Scholar
• Chester, K.A. et al Phage libraries for generation of clinically useful antibodies. Lancet 343, 455–456 (1994).
  Article CAS Google Scholar
• Griffiths, A.D. et al Isolation of high affinity human antibodies directly from large synthetic repertoires. EMBOJ. 13, 3245–3260 (1994).
  Article CAS Google Scholar
• Verhaar, M.J. et al A single chain Fv derived from a filamentous phage library has distinct tumour targeting advantages over one derived from a hybridoma. Int.J. Cancer 61, 497–501 (1995).
  Article CAS Google Scholar
• Casey, J.L. et al Purification of bacterially expressed single chain Fv antibodies for clinical applications using metal chelate chromatography. J. Immunol Methods 179, 105–116 (1995).
  Article CAS Google Scholar
• Campaign operation manual for control of production, preclinical toxicology and phase I trials of anti tumour antibodies and drug antibody conjugates. Br. J. Cancer 54, 557–568 (1986).
• Houghten, R.A. et al Generation and use of synthetic peptide combinatorial libraries for basic research and drug discovery. Nature 354, 84–86 (1991).
  Article CAS Google Scholar
• Tuerk, C. & Gold, L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 249, 505–510 (1990).
  Article CAS Google Scholar
• Bunin, B.A., Plunket, M.J. & Ellman, J.A. The combinatorial synthesis and chemical and biological evaluation of a 1,4-benzodiazepine library. Proc. Natl. Acad. Sci. USA 91, 4708–4712 (1994).
  Article CAS Google Scholar
• Green, A.J., Dewhurst, S.E., Begent, R.H., Bagshawe, K.D. & Riggs, S.J. Accurate quantification of 131I distribution by gamma camera imaging. Eur. J. Nucl. Med. 16, 361–365 (1990).
  Article CAS Google Scholar
• Lane, D.M. et al Radioimmunotherapy of metastatic colorectal tumours with iodine-131-labeled antibody to carcinoembryonic antigen: Phase I/II study with comparative biodistribution of intact and F(ab')2 antibodies. Br. J. Cancer 70, 521–525 (1994).
  Article CAS Google Scholar
• Begent, R.H.J. J. etal. Antibody distribution and dosimetry in patients receiving radi-olabelled antibody therapy for colorectal cancer. Br. J. Cancer 60, 406–412 (1989).
  Article CAS Google Scholar
• Takakura, Y., Fujita, T., Hashido, M. & Sezoni, H. Disposition characteristics of macromolecules in tumour-bearing mice. Pharm. Res. 7, 339–346 (1990).
  Article CAS Google Scholar
• Michael, N.P. et al In vitro and in vivo characterisation of a recombinant car-boxypeptidase G2::anti-CEA scFv fusion protein. Immunotechnology 2, 47–57 (1996).
  Article CAS Google Scholar
• Bagshawe, K.D., Sharma, S.K., Springer, C.S. & Antoniw, P. Antibody directed enzyme prodrug therapy: Pilot scale clinical trial. Tumour Target. 1, 17–29 (1995).
  Google Scholar
• Yang, W-P. et al. CDR walking mutagenesis for the affinity maturation of a potent human anti-HIV antibody into the picomolar range. J. Mol. Biol. 254, 392–403 (1995).
  Article CAS Google Scholar
• Barbas, C.F. III.Synthetic human antibodies. Nature Med. 1, 837–839 (1995).
  Article CAS Google Scholar
• Melton, R.G. et al. Optimisation of small-scale coupling of A5B7 monoclonal antibody to carboxypeptidase G2. J. Immunol. Methods 158, 49–56 (1993).
  Article CAS Google Scholar
• Moertel, C.G. Chemotherapy for colorectal cancer. N. Engl. J. Med. 330, 1136–1142(1994).
• Glimelius, B. B for the Nordic Gastrointestinal Tumour Adjuvant Therapy Group. Expectancy or primary chemotherapy in patients with advanced asymptomatic colorectal cancer: A randomized trial. Eur. J. Cancer S82 (Suppl. 2), 462 (1991).
  Google Scholar
• Verhaar, M.J. et al. 99mTc radiolabelling using a phage-derived single chain Fv with C-terminal cysteine for colorectal tumour imaging. J. Nucl. Med. 37, 868–872 (1996).
  CAS PubMed Google Scholar
• Begent, R.H.J. et al Cancer Research Campaign operation manual for control recommendations for products derived from recombinant DNA technology prepared for investigational administration to patients with cancer in phase I trials. Eur. J. Cancer 29A, 1907–1910 (1993).
  Article CAS Google Scholar
• Hunter, W.M. & Greenwood, F.C. Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature 194, 495–496 (1962).
  Article CAS Google Scholar
• Ledermann, J.A. et al. A phase-I study of repeated therapy with radiolabelled antibody to carcinoembryonic antigen using intermittent or continuous administration of cyclosporin A to suppress the immune response. Int. J. Cancer 47, 659–664 (1991).
  Article CAS Google Scholar